USPTO serial 79398397
SERB PHARMACEUTICALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 15, 2025
- Examiner
- DOMBROW, COLLEEN M
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SERB PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sherry L. Rollo
Sherry L. Rollo Hahn Loeser & Parks, LLP200 W. Madison St., Suite 2700Chicago, IL 60606United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific use, other than for medical or veterinary use; Chemical substances for scientific use for analyses in laboratories, other than for medical or veterinary use; chemical preparations and substances with or without coloring agents for laboratory analyses, other than for medical or veterinary use; chemical preparations for scientific purposes other than for medical or veterinary use; diagnostic preparations and substances in the nature of chemicals with or without coloring agents other than for medical or veterinary use, namely, chemical diagnostic reagents for industrial purposes; chemical additives with or without coloring agents used in the composition of diagnostic preparations and substances, namely, chemical additives for use in the manufacture of pharmaceuticals; chemical reagents with or without coloring agents, other than for medical or veterinary use, namely, chemical reagents for non-medical purposes; active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of snake bite venom, the treatment of digoxin toxicity and overdose, the treatment of methotrexate toxicity and overdose, the treatment of exposure to nuclear radiation and the treatment of cyanide poisoning. | ACTIVE | — |
| 005 | Pharmaceutical preparations, medicines and substances, namely, pharmaceutical preparations for treating poisonings, overdoses of any type, allergies, snake bites, exposure to nuclear radiations, infections, tumors, heart diseases, blood diseases, skin diseases, gastric diseases, liver diseases, neurological diseases, ophthalmological diseases, lung diseases, rheumatological diseases, rare ocular diseases; Pharmaceutical preparations for the treatment of snake bite venom; Pharmaceutical preparations for the treatment of digoxin toxicity and overdose; Pharmaceutical preparations for the treatment of methotrexate toxicity and overdose; Pharmaceutical preparations, namely, potassium iodide, for the treatment of exposure to nuclear radiation; Pharmaceutical preparations for the treatment of cyanide poisoning; Antidotes; veterinary preparations, medicines and substances, namely, veterinary preparations of snake bite venom to treat snake bites, veterinary preparations for the treatment of digoxin toxicity and overdose, veterinary preparations for the treatment of methotrexate toxicity and overdose, veterinary preparations for the treatment of cyanide poisoning; Biological preparations for medical, pharmaceutical and veterinary use, namely, biological preparations for the treatment of cancer; radioactive substances for medical use; dietetic beverages and foods adapted for medical use; nutritional supplements for medical use; diagnostic preparations for medical or veterinary use; chemical reagents for medical or veterinary use; radiological contrast substances for medical use; herbal tinctures for medical use; surgical implants made of living tissue; medical and veterinary microbial media, namely, cell culture media for medical and veterinary use; cultures of microorganisms for medical or veterinary use; antibiotic preparations; dressings for medical use. | ACTIVE | — |
| 010 | Surgical apparatus and instruments for medical, dental and veterinary use; infusion apparatus for therapeutic use; thermometers for medical use; Artificial implants, namely, implants consisting of artificial materials; stents; Dental prostheses; cardiac pacemakers; lenses in the nature of intraocular prostheses for surgical implantation; Orthopedic articles, namely, orthopedic braces for the prevention and the correction of disorders of the musculoskeletal system affecting bones, joints, muscles, tendons and nerves; x-ray apparatus for medical use; Electromagnetic medical diagnostic imaging apparatus; Medical diagnostic instruments for the analysis of body fluids; Medical diagnostic equipment, namely, diagnostic penlights for medical purposes | ACTIVE | — |
| 042 | Medical research services; Scientific research for medical use; pharmaceutical diagnostic testing services, namely, testing of pharmaceuticals; pharmaceutical diagnostic testing services, namely, scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals; Research and development of new products; assessment in scientific and technical fields provided by engineers, namely, consulting in the field of engineering; Appraisals in the fields of science and technology provided by engineers, namely, conducting scientific feasibility studies; scientific research; Technical and scientific studies, namely, conducting scientific feasibility studies | ACTIVE | — |
| 044 | Medical services; medical assistance; veterinary services; consultation with respect to pharmacy, namely, pharmaceutical consultation. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SERB
- Other trademarks owned by SERB
- Other trademarks owned by SERB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SERB PHARMACEUTICALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 26, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 6, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 6, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 11, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 26, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 26, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 15, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 15, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 15, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 27, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 27, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 21, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 29, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 29, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 29, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 29, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 29, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 24, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 24, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 24, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 23, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 3, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 3, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 3, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 30, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 30, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 30, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 9, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 20, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 20, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 13, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 12, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 9, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 1, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 1, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 27, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |